Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Synageva BioPharma Corp Announces 2.75 Million Share Proposed Public Offering Of Common Stock

Monday, 23 Sep 2013 04:10pm EDT 

Synageva BioPharma Corp announced that it intends to offer for sale 2.75 million shares of its common stock in an underwritten public offering. In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase up to an additional 412,500 shares of its common stock. If the underwriters exercise this option, Synageva will have offered 3.16 million shares of its common stock. Goldman, Sachs & Co. is acting as the sole book-running manager in the offering. 

Company Quote

-4.95 -6.42%
28 Aug 2014